![Hong Sheng Xu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hong Sheng Xu
Vorstandsvorsitzender bei Shapuaisi Qiangshen Pharma Co., Ltd.
Aktive Positionen von Hong Sheng Xu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Shapuaisi Qiangshen Pharma Co., Ltd.
![]() Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - |
Karriereverlauf von Hong Sheng Xu
Ehemalige bekannte Positionen von Hong Sheng Xu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Direktor/Vorstandsmitglied | 25.09.2018 | - |
Vorsitzender | 25.09.2018 | - |
Statistik
International
China | 3 |
Operativ
Director/Board Member | 2 |
Chairman | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Shapuaisi Qiangshen Pharma Co., Ltd.
![]() Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million. | Health Technology |
- Börse
- Insiders
- Hong Sheng Xu
- Erfahrung